VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q56654206  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000241.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q56654206‏
024 ‎‡a  0000-0002-7220-4833‏ ‎‡2  orcid‏
024 ‎‡a  43861409600‏ ‎‡2  scopus‏
024 ‎‡a  57191729815‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q56654206‏
100 0 ‎‡a  Meng-Rui Lee‏ ‎‡9  es‏ ‎‡9  ast‏
400 0 ‎‡a  Meng-Rui Lee‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Meng-Rui Lee‏ ‎‡c  onderzoeker‏ ‎‡9  nl‏
400 0 ‎‡a  李孟叡‏ ‎‡c  研究者‏ ‎‡9  zh‏
670 ‎‡a  Author's Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities‏
670 ‎‡a  Author's Acute biliary events during anti-tuberculosis treatment: hospital case series and a nationwide cohort study‏
670 ‎‡a  Author's Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.‏
670 ‎‡a  Author's CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status‏
670 ‎‡a  Author's Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014.‏
670 ‎‡a  Author's Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates.‏
670 ‎‡a  Author's Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.‏
670 ‎‡a  Author's CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates‏
670 ‎‡a  Author's Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis‏
670 ‎‡a  Author's Differed IL-1 Beta Response between Active TB and LTBI Cases by Ex Vivo Stimulation of Human Monocyte-Derived Macrophage with TB-Specific Antigen‏
670 ‎‡a  Author's Differences in drug resistance profiles of Mycobacterium tuberculosis isolates causing pulmonary and extrapulmonary tuberculosis in a medical centre in Taiwan, 2000-2010‏
670 ‎‡a  Author's Diffuse panbronchiolitis‏
670 ‎‡a  Author's Epidemiologic surveillance to detect false-positive Mycobacterium tuberculosis cultures.‏
670 ‎‡a  Author's Evaluation of the Cobas TaqMan MTB real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory specimens.‏
670 ‎‡a  Author's Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease‏
670 ‎‡a  Author's High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis‏
670 ‎‡a  Author's Identification of Weissella species by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.‏
670 ‎‡a  Author's Infections caused by Candida lipolytica‏
670 ‎‡a  Author's Infections caused by unusual Methylobacterium species.‏
670 ‎‡a  Author's Isoniazid Concentration and NAT2 Genotype Predict Risk of Systemic Drug Reactions during 3HP for LTBI‏
670 ‎‡a  Author's Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study‏
670 ‎‡a  Author's Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous Mycobacteria‏
670 ‎‡a  Author's Photo quiz: fever and progressive swelling of the left thigh in a female heroin addict with diabetes mellitus. Klebsiella pneumoniae.‏
670 ‎‡a  Author's Plasma Biomarkers Can Predict Treatment Response in Tuberculosis Patients: A Prospective Observational Study.‏
670 ‎‡a  Author's Polymorphisms Are Genetic Markers for Vulnerability to Latent and Active Tuberculosis Infection in Taiwan‏
670 ‎‡a  Author's Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study.‏
670 ‎‡a  Author's Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma.‏
670 ‎‡a  Author's Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration‏
670 ‎‡a  Author's Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis.‏
670 ‎‡a  Author's Shared Embedding of X-ray & Enose Networks for Lung Cancer Classification‏
670 ‎‡a  Author's Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease.‏
670 ‎‡a  Author's Use of Antiplatelet Agents and Survival of Tuberculosis Patients: A Population-Based Cohort Study‏
909 ‎‡a  (scopus) 57191729815‏ ‎‡9  1‏
909 ‎‡a  (scopus) 43861409600‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000272204833‏ ‎‡9  1‏
919 ‎‡a  updateontuberculosisbiomarkersfromcorrelatesofrisktocorrelatesofactivediseaseandofcurefromdisease‏ ‎‡A  Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease.‏ ‎‡9  1‏
919 ‎‡a  useofantiplateletagentsandsurvivaloftuberculosispatientsapopulationbasedcohortstudy‏ ‎‡A  Use of Antiplatelet Agents and Survival of Tuberculosis Patients: A Population-Based Cohort Study‏ ‎‡9  1‏
919 ‎‡a  evaluationofthecobastaqmanmtbrealtimepcrassayfordirectdetectionofmycobacteriumtuberculosisinrespiratoryspecimens‏ ‎‡A  Evaluation of the Cobas TaqMan MTB real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory specimens.‏ ‎‡9  1‏
919 ‎‡a  factorsassociatedwithlungfunctiondeclineinpatientswithnontuberculousmycobacterialpulmonarydisease‏ ‎‡A  Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease‏ ‎‡9  1‏
919 ‎‡a  highlevelsofserummacrophagemigrationinhibitoryfactorandinterleukin10areassociatedwitharapidlyfataloutcomeinpatientswithseveresepsis‏ ‎‡A  High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis‏ ‎‡9  1‏
919 ‎‡a  identificationofweissellaspeciesbymatrixassistedlaserdesorptionionizationtimeofflightmassspectrometry‏ ‎‡A  Identification of Weissella species by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.‏ ‎‡9  1‏
919 ‎‡a  infectionscausedbycandidalipolytica‏ ‎‡A  Infections caused by Candida lipolytica‏ ‎‡9  1‏
919 ‎‡a  infectionscausedbyunusualmethylobacteriumspecies‏ ‎‡A  Infections caused by unusual Methylobacterium species.‏ ‎‡9  1‏
919 ‎‡a  isoniazidconcentrationandnat2genotypepredictriskofsystemicdrugreactionsduring3hpforltbi‏ ‎‡A  Isoniazid Concentration and NAT2 Genotype Predict Risk of Systemic Drug Reactions during 3HP for LTBI‏ ‎‡9  1‏
919 ‎‡a  outcomeofstage4cancerpatientsreceivinginhospitalcardiopulmonaryresuscitationapopulationbasedcohortstudy‏ ‎‡A  Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study‏ ‎‡9  1‏
919 ‎‡a  performanceassessmentofthedrtbdrntmivdkitfordirectdetectionofmycobacteriumtuberculosisisolatesincludingrifampinresistantisolatesandnontuberculousmycobacteria‏ ‎‡A  Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous Mycobacteria‏ ‎‡9  1‏
919 ‎‡a  photoquizfeverandprogressiveswellingoftheleftthighinafemaleheroinaddictwithdiabetesmellitusklebsiellapneumoniae‏ ‎‡A  Photo quiz: fever and progressive swelling of the left thigh in a female heroin addict with diabetes mellitus. Klebsiella pneumoniae.‏ ‎‡9  1‏
919 ‎‡a  plasmabiomarkerscanpredicttreatmentresponseintuberculosispatientsaprospectiveobservationalstudy‏ ‎‡A  Plasma Biomarkers Can Predict Treatment Response in Tuberculosis Patients: A Prospective Observational Study.‏ ‎‡9  1‏
919 ‎‡a  polymorphismsaregeneticmarkersforvulnerabilitytolatentandactivetuberculosisinfectionintaiwan‏ ‎‡A  Polymorphisms Are Genetic Markers for Vulnerability to Latent and Active Tuberculosis Infection in Taiwan‏ ‎‡9  1‏
919 ‎‡a  prognosticfactorsofafatinibasa1linetherapyforadvancedegfrmutationpositivelungadenocarcinomaarealworldlargecohortstudy‏ ‎‡A  Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study.‏ ‎‡9  1‏
919 ‎‡a  realworldexperienceofafatinibasa1linetherapyforadvancedegfrmutationpositivelungadenocarcinoma‏ ‎‡A  Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma.‏ ‎‡9  1‏
919 ‎‡a  riskfactorsformycobacteriumchelonaeabscessuspulmonarydiseasepersistenceanddeterioration‏ ‎‡A  Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration‏ ‎‡9  1‏
919 ‎‡a  epidemiologicsurveillancetodetectfalsepositivemycobacteriumtuberculosiscultures‏ ‎‡A  Epidemiologic surveillance to detect false-positive Mycobacterium tuberculosis cultures.‏ ‎‡9  1‏
919 ‎‡a  diffusepanbronchiolitis‏ ‎‡A  Diffuse panbronchiolitis‏ ‎‡9  1‏
919 ‎‡a  differencesindrugresistanceprofilesofmycobacteriumtuberculosisisolatescausingpulmonaryandextrapulmonarytuberculosisinamedicalcentreintaiwan2000‏ ‎‡A  Differences in drug resistance profiles of Mycobacterium tuberculosis isolates causing pulmonary and extrapulmonary tuberculosis in a medical centre in Taiwan, 2000-2010‏ ‎‡9  1‏
919 ‎‡a  differedil1betaresponsebetweenactivetbandltbicasesbyexvivostimulationofhumanmonocytederivedmacrophagewithtbspecificantigen‏ ‎‡A  Differed IL-1 Beta Response between Active TB and LTBI Cases by Ex Vivo Stimulation of Human Monocyte-Derived Macrophage with TB-Specific Antigen‏ ‎‡9  1‏
919 ‎‡a  diabetesmellitusandlatenttuberculosisinfectionasystemicreviewandmetaanalysis‏ ‎‡A  Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis‏ ‎‡9  1‏
919 ‎‡a  cnsinfectionscausedbymycobacteriumabscessuscomplexclinicalfeaturesandantimicrobialsusceptibilitiesofisolates‏ ‎‡A  CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates‏ ‎‡9  1‏
919 ‎‡a  clinicalfeaturesofpatientswithbacteraemiacausedbymycobacteriumaviumcomplexspeciesandantimicrobialsusceptibilityoftheisolatesatamedicalcentreintaiwan2008‏ ‎‡A  Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.‏ ‎‡9  1‏
919 ‎‡a  clinicalcharacteristicsofinfectionscausedbyroseomonasspeciesandantimicrobialsusceptibilitiesoftheisolates‏ ‎‡A  Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates.‏ ‎‡9  1‏
919 ‎‡a  clinicalcharacteristicsofbacteraemiacausedbylactobacillussppandantimicrobialsusceptibilitiesoftheisolatesatamedicalcentreintaiwan2000‏ ‎‡A  Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014.‏ ‎‡9  1‏
919 ‎‡a  cd8responsemeasuredbyquantiferontbgoldplusandtuberculosisdiseasestatus‏ ‎‡A  CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status‏ ‎‡9  1‏
919 ‎‡a  capsularserotypesandantimicrobialsusceptibilitiesofstreptococcuspneumoniaecausinginvasivepneumococcaldiseasefrom20092012withanemphasisonserotype19ainbacteraemicpneumoniaandempyemaandβlactamresistance‏ ‎‡A  Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.‏ ‎‡9  1‏
919 ‎‡a  acutebiliaryeventsduringantituberculosistreatmenthospitalcaseseriesandanationwidecohortstudy‏ ‎‡A  Acute biliary events during anti-tuberculosis treatment: hospital case series and a nationwide cohort study‏ ‎‡9  1‏
919 ‎‡a  acquisitionofmycobacteriumabscessusamongventilatordependentpatientsintaiwanchronicrespiratorycarefacilities‏ ‎‡A  Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities‏ ‎‡9  1‏
919 ‎‡a  severelymphopeniaisassociatedwithelevatedplasmainterleukin15levelsandincreasedmortalityduringseveresepsis‏ ‎‡A  Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis.‏ ‎‡9  1‏
919 ‎‡a  sharedembeddingof10ray&ampenosenetworksforlungcancerclassification‏ ‎‡A  Shared Embedding of X-ray & Enose Networks for Lung Cancer Classification‏ ‎‡9  1‏
943 ‎‡a  201x‏ ‎‡A  2010‏ ‎‡9  3‏
996 ‎‡2  LC|nb2010001264‏
996 ‎‡2  ISNI|0000000035524307‏
996 ‎‡2  LC|n 2020182128‏
996 ‎‡2  PLWABN|9812424908005606‏
996 ‎‡2  ISNI|0000000509712714‏
996 ‎‡2  ISNI|0000000467787127‏
996 ‎‡2  BIBSYS|66772‏
996 ‎‡2  ISNI|000000050840316X‏
996 ‎‡2  ISNI|0000000472495102‏
996 ‎‡2  ISNI|0000000505548574‏
996 ‎‡2  ISNI|0000000062634173‏
996 ‎‡2  ISNI|000000047356064X‏
996 ‎‡2  ISNI|0000000491656530‏
996 ‎‡2  LC|n 78065442‏
996 ‎‡2  LC|n 2024017486‏
996 ‎‡2  BNF|16995559‏
996 ‎‡2  NTA|190010436‏
996 ‎‡2  ISNI|0000000050659656‏
996 ‎‡2  BIBSYS|99013348‏
996 ‎‡2  ISNI|0000000493190885‏
996 ‎‡2  ISNI|0000000491660601‏
996 ‎‡2  BLBNB|000564996‏
996 ‎‡2  SUDOC|102306079‏
996 ‎‡2  LC|nb2016008631‏
996 ‎‡2  ISNI|0000000459448803‏
996 ‎‡2  PLWABN|9814067371905606‏
996 ‎‡2  J9U|987012797906105171‏
996 ‎‡2  ISNI|0000000049458478‏
996 ‎‡2  ISNI|0000000467831466‏
996 ‎‡2  ISNI|000000050821190X‏
996 ‎‡2  SUDOC|268793883‏
996 ‎‡2  ISNI|0000000464761079‏
996 ‎‡2  CYT|AC000618724‏
996 ‎‡2  LC|nr 98016196‏
996 ‎‡2  SUDOC|085856843‏
996 ‎‡2  ISNI|0000000491926529‏
996 ‎‡2  ISNI|0000000077346772‏
996 ‎‡2  ISNI|0000000505543220‏
996 ‎‡2  ISNI|0000000468599195‏
996 ‎‡2  BIBSYS|99038785‏
996 ‎‡2  SUDOC|250053349‏
996 ‎‡2  BLBNB|000296303‏
996 ‎‡2  LC|nb2007027448‏
996 ‎‡2  BIBSYS|4052738‏
996 ‎‡2  ISNI|0000000461091137‏
996 ‎‡2  DNB|133486540‏
996 ‎‡2  ISNI|0000000037423833‏
996 ‎‡2  DNB|170980103‏
996 ‎‡2  ISNI|0000000485113791‏
996 ‎‡2  ISNI|0000000464841028‏
996 ‎‡2  ISNI|0000000023063814‏
996 ‎‡2  DBC|87097991346699‏
996 ‎‡2  LC|no 98036636‏
996 ‎‡2  LC|nb2009015797‏
996 ‎‡2  ISNI|000000046442550X‏
996 ‎‡2  BNF|16192296‏
996 ‎‡2  NII|DA13807144‏
996 ‎‡2  ISNI|0000000464681159‏
996 ‎‡2  LC|n 2019184385‏
996 ‎‡2  LC|nb 99067980‏
996 ‎‡2  ISNI|0000000491971223‏
996 ‎‡2  ISNI|0000000377252129‏
996 ‎‡2  LC|no2008059106‏
996 ‎‡2  ISNI|0000000465100344‏
996 ‎‡2  BIBSYS|12034533‏
996 ‎‡2  CAOONL|ncf10720213‏
996 ‎‡2  DNB|1178865398‏
996 ‎‡2  CAOONL|ncf10039232‏
996 ‎‡2  RERO|A023766042‏
996 ‎‡2  ISNI|0000000493014208‏
996 ‎‡2  ISNI|0000000464864342‏
996 ‎‡2  ISNI|0000000483566463‏
996 ‎‡2  BIBSYS|97012034‏
996 ‎‡2  J9U|987007360162905171‏
996 ‎‡2  LC|n 83003857‏
996 ‎‡2  LC|n 2007073655‏
996 ‎‡2  ISNI|0000000491675950‏
996 ‎‡2  SUDOC|273864130‏
996 ‎‡2  ISNI|0000000081347380‏
996 ‎‡2  ISNI|0000000475896235‏
996 ‎‡2  J9U|987007327546705171‏
996 ‎‡2  RERO|A003507522‏
996 ‎‡2  LC|n 2018186276‏
996 ‎‡2  LC|nb2023003476‏
996 ‎‡2  NTA|274156792‏
996 ‎‡2  ISNI|0000000492170348‏
996 ‎‡2  J9U|987007453587305171‏
996 ‎‡2  SUDOC|201431548‏
996 ‎‡2  ISNI|0000000047891964‏
996 ‎‡2  NTA|107914077‏
996 ‎‡2  RERO|A013981325‏
996 ‎‡2  RERO|A013621470‏
996 ‎‡2  BNC|981058615494506706‏
996 ‎‡2  ISNI|0000000492103161‏
996 ‎‡2  ISNI|0000000064368155‏
996 ‎‡2  ISNI|0000000025621007‏
996 ‎‡2  N6I|vtls000078541‏
996 ‎‡2  ISNI|0000000491932953‏
996 ‎‡2  SUDOC|221780203‏
996 ‎‡2  NTA|363430369‏
996 ‎‡2  ISNI|0000000467901858‏
996 ‎‡2  NSK|000344553‏
996 ‎‡2  DNB|171374886‏
996 ‎‡2  ISNI|0000000492515780‏
996 ‎‡2  LC|n 99253751‏
996 ‎‡2  DNB|1089711158‏
996 ‎‡2  ISNI|0000000496680652‏
996 ‎‡2  ISNI|0000000112508096‏
996 ‎‡2  ISNI|0000000505786011‏
996 ‎‡2  ISNI|0000000505412538‏
996 ‎‡2  SUDOC|075204827‏
996 ‎‡2  NII|DA08906409‏
996 ‎‡2  ISNI|0000000472234148‏
996 ‎‡2  LC|n 80148176‏
996 ‎‡2  DNB|128033363‏
996 ‎‡2  BNF|17914731‏
996 ‎‡2  J9U|987007369770705171‏
996 ‎‡2  ISNI|0000000045888454‏
996 ‎‡2  BIBSYS|90958892‏
996 ‎‡2  LC|n 95071376‏
996 ‎‡2  LC|no 94022778‏
996 ‎‡2  ISNI|0000000072293413‏
996 ‎‡2  ISNI|0000000468323535‏
996 ‎‡2  ISNI|0000000512739563‏
996 ‎‡2  ISNI|0000000479110762‏
996 ‎‡2  ISNI|0000000493134154‏
996 ‎‡2  ISNI|0000000459350339‏
996 ‎‡2  SUDOC|174661045‏
996 ‎‡2  ISNI|0000000476808532‏
996 ‎‡2  LC|n 2007043502‏
996 ‎‡2  ISNI|0000000459348140‏
996 ‎‡2  DNB|1268386960‏
996 ‎‡2  DNB|1228985472‏
996 ‎‡2  ISNI|0000000479338142‏
996 ‎‡2  ISNI|0000000491675723‏
996 ‎‡2  LC|nb2011001505‏
996 ‎‡2  NII|DA05877144‏
996 ‎‡2  ISNI|0000000483575597‏
996 ‎‡2  NTA|364176407‏
996 ‎‡2  DNB|13286956X‏
996 ‎‡2  LC|n 80002796‏
996 ‎‡2  ISNI|0000000460885437‏
996 ‎‡2  SUDOC|255154720‏
996 ‎‡2  BNF|12367865‏
996 ‎‡2  NUKAT|n 2017077495‏
996 ‎‡2  LC|n 90615440‏
996 ‎‡2  LC|no2008166554‏
996 ‎‡2  ISNI|0000000492139658‏
996 ‎‡2  ISNI|0000000063882590‏
996 ‎‡2  ISNI|0000000513220210‏
996 ‎‡2  NSK|000356851‏
996 ‎‡2  ISNI|0000000512790035‏
996 ‎‡2  ISNI|0000000479337991‏
996 ‎‡2  ISNI|0000000491599767‏
996 ‎‡2  LC|no2008183114‏
996 ‎‡2  J9U|987012501636005171‏
996 ‎‡2  J9U|987007326009905171‏
996 ‎‡2  ISNI|0000000117757956‏
996 ‎‡2  ISNI|0000000492135585‏
996 ‎‡2  ISNI|0000000492133141‏
996 ‎‡2  ISNI|0000000492133336‏
996 ‎‡2  ISNI|0000000516903594‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏